The SureTouch  Exam™ is changing the way the world  detects breast cancer. From a patient perspective, a clinical exam with SureTouch is comfortable and affordable. From a provider perspective, SureTouch is accurate and easily administered. At last, women of all ages across a broad socio-economic range can receive a level of care and critical screening that would be otherwise unavailable.

Medical Tactile, Inc. (MTI) is committed to creating affordable, easy to use diagnostic devices that enhance and quantify the traditional process of manual palpation for breast cancer screening. The debut of SureTouch represents MTI’s first phase in the development of tactile sensing technology that improves early detection of breast cancer and ultimately save lives.